News
22mon MSN
The FDA's approval of lenacapavir, a highly effective HIV prevention drug, sparks debate in India due to its high cost of ₹24 ...
HIV and global health activists say the deployment of Gilead’s twice-a-year HIV prevention shot is the world’s best chance to ...
The United States has approved a twice-a-year jab that almost entirely protects against HIV in what’s being hailed as a ...
The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...
The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...
The drug, lamivudine, appears to improve vision that’s being threatened by diabetic macular edema (DME), an eye condition in ...
General, Winnie Byanyima, has called for a drastic and transparent reduction in the cost of lenacapavir, a twice-yearly ...
More than a million people are infected every year with the Human Immunodeficiency Virus (HIV), despite decades of work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results